Sopoongsan inhibits mast cell-mediated anaphylactic reactions and inflammatory cytokine secretion

International Archives of Allergy and Immunology

Volumn 139, Issue 1, 2005, Pages 31-37

  Na, Ho Jeong ^a   Jeong, Hyun Ja ^b,c   Shin, Hye Young ^c   Kim, Nam Song ^d   Um, Jae Young ^b   Hong, Seung Heon ^c   Kim, Hyung Min ^b  

^a Woosuk University   (South Korea)

^b Kyung Hee University   (South Korea)

^c Wonkwang University   (South Korea)

^d Wonkwang University School of Medicine   (South Korea)

Author keywords

Atopic dermatitis; Cytokines; Histamine; Mast cells; Passive cutaneous anaphylaxis; Sopoongsan

Indexed keywords

HERBACEOUS AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE; SOPOONGSAN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANAPHYLAXIS; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HUMAN; HUMAN CELL; MAST CELL; PERITONEUM; PRIORITY JOURNAL; WESTERN BLOTTING;

ADMINISTRATION, ORAL; ANIMALS; ANTI-ALLERGIC AGENTS; CYTOKINES; DERMATITIS, ATOPIC; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; HISTAMINE; HUMANS; MAST CELLS; MICE; MICE, INBRED ICR; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; P-METHOXY-N-METHYLPHENETHYLAMINE; PASSIVE CUTANEOUS ANAPHYLAXIS; PLANT EXTRACTS; RATS;

EID: 30044446680     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000089520     Document Type: Article

References (24)

1. Soter NA: Morphology of atopic eczema. Allergy 1989:44(suppl 9):16-19.
2. White M: Mediators of inflammation and the inflammatory process. J Allergy Clin Immunol 1999;103:S378-S381.
3. Guo Y, Mochizuki T, Morii E, Kitamura Y, Maeyama K: Role of mast cell histamine in the formation of rat paw edema: a microdialysis study. Eur J Pharmacol 1997;331:237-243.
4. Herman SM, Vender RB: Antihistamines in the treatment of atopic dermatitis. J Cutan Med Surg 2003;7:467-473.
5. Kim MS, Na HJ, Han SW, Jin JS, Song UY, Lee EJ, Song BK, Hong SH, Kim HM: Forsythia fructus inhibits the mast-cell-mediated allergic inflammatory reactions. Inflammation 2003;27:129-135.
6. Kim HM, Yang DJ: Effect of Kumhwang-San on anaphylactic reaction in a murine model. Immunopharmacol Immunotoxicol 1999;21:163-174.
7. Kobayashi H, Ishizuka T, Okayama Y: Human mast cells and basophils as sources of cytokines. Clin Allergy Immunol 2000;17:101-139.
8. Ackermann L, Harvima IT: Mast cells of psoriatic and atopic dermatitis skin are positive for TNF-α and their degranulation is associated with expression of ICAM1 in the epidermis. Arch Dermatol Res 1998;290:353-359.
9. Garrington TP, Johnson GL: Organization and regulation of mitogen-activated protein kinase signaling pathways. Curr Opin Cell Biol 1999;11:211-218.
10. Baeuerle PA, Henkel T: Function and activation of NF-kappa B in immune systems. Annu Rev Immunol 1994;12:141-179.
11. Na HJ, Jeong HJ, Bae H, Kim YB, Park ST, Yun YG, Kim HM: Tongkyutang inhibits mast cell dependent allergic reactions and inflammatory cytokines secretion. Clin Chim Acta 2002;319:35-41.
12. Yurt RW, Leid RW, Austen KF: Native heparin from rat peritoneal mast cells. J Biol Chem 1977;252:518-521.
13. Shore PA, Burkhalter A, Cohn VH: A method for fluorometric assay of histamine in tissues. J Pharmacol Exp Ther 1959;127:182-186.
14. Katayama S, Shionoya H, Ohtake S: A new method for extraction of extravasated dye in the skin and the influence of fasting stress on passive cutaneous anaphylaxis in guinea pigs and rats. Microbiol Immunol 1978;22:89-101.
15. Schoonbroodt S, Legrand-Poels S, Best-Belpomme M, Piette J: Activation of the NF-kappaB transcription factor in a T-lymphocytic cell line by hypochlorous acid. Biochem J 1997;321:777-785.
16. Alfonso A, Cabado AG, Vieytes MR, Botana LM: Functional compartments in rat mast cells for cAMP and calcium on histamine release. Cell Signal 2000;12:343-350.
17. Mousli MC, Bronner C, Bockaert J, Rouot B, Landry Y: Interaction of substance P, compound 48/80 and mastoparan with α-subunit C-terminal of G protein. Immunol Lett 1990;25:355-357.
18. Galli SJ: New concepts about the mast cell. N Engl J Med 1993;328:257-265.
19. Moller C, Xiang Z, Nilsson G: Activation of mast cells by immunoglobulin E-receptor cross-linkage, but not through adenosine receptors, induces A1 expression and promotes survival. Clin Exp Allergy 2003;33:1135-1140.
20. Moller A, Henz BM, Grutzkau A, Lippert U, Aragane Y, Schwarz T, Kruger-Krasagakes S: Comparative cytokine gene expression: regulation and release by human mast cells. Immunology 1998;93:289-295.
21. Barens PJ, Karin M: NF-κB: a pivotal role in chronic inflammatory disease. N Engl J Med 1997;336:1066-1069.
22. May MJ, Ghosh S: Signal transduction through NF-kappa B. Immunol Today 1998;19:80-88.
23. Adwanikar H, Karim F, Gereau RW 4th: Inflammation persistently enhances nocifensive behaviors mediated by spinal group I mGluRs through sustained ERK activation. Pain 2004;111:125-135.
24. Koranteng RD, Swindle EJ, Davis BJ, Dearman RJ, Kimber I, Flanagan BF, Coleman JW: Differential regulation of mast cell cytokines by both dexamethasone and the p38 mitogen-activated protein kinase (MAPK) inhibitor SB203580. Clin Exp Immunol 2004;137:81-87.